HIPRA, as a market reference in prevention for animal health, will be sponsoring the event and contributing knowledge and future solutions to problems in relation to animal health that have an important effect on the swine production sector.

As part of the Congress programming, HIPRA will present various studies and research conducted by the company in different countries where it is located in relation to swine flu and its vaccine against the disease, GRIPORK®, as well as field work on PRRS.

In addition, HIPRA has programmed a satellite Symposium to take place in the Barcelona Congress Centre that will be held on 14 June in the afternoon within the context of the event's activities.

The Symposium will deal with new research into the PRRS disease and cover various field aspects for controlling and preventing the clinical problems in relation to the PRRS virus. In the talks given, AMERVAC® PRRS, HIPRA's live vaccine against the PRRS disease, will be the event's main attraction. The product's efficacy will be demonstrated and various solutions provided for the multiple field cases that appear in relation with this disease from a local, regional and global point of view.

Further Reading

-

Find out more information on porcine reproductive respiratory syndrome (PRRS) by clicking here.